healtheo360 presents: Exchange - A Conversation With Scott Jackson from Celator Pharmaceuticals
2948 Story Views
healtheo360 presents: Exchange - A Conversation With Scott Jackson from Celator Pharmaceuticals
About this video:
Dave sits down with Scott Jackson from Celator Pharmaceuticals at the JP Morgan Annual Health Conference. In this interview, they talk about VYXEOS and their CombiPlex proprietary platform to develop synergistic therapy combinations for patients with acute myeloid leukemia.
Comments
Sign in or 
to post a comment on this story!
to post a comment on this story!
